{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:17:09Z","timestamp":1744258629888,"version":"3.40.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Public Health"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.17269\/s41997-022-00609-9","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T21:06:10Z","timestamp":1644613570000},"page":"196-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is vaccine hesitancy justified? Benchmarking post-market vaccine risks with five commonly used medicinal products in Canada"],"prefix":"10.17269","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7226-9928","authenticated-orcid":false,"given":"Tuhin","family":"Maity","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"von Schlegell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"unstructured":"Annual Report on Vaccine Safety. (2021). [Public Health Ontario]. Vaccine Safety Surveillance Archive. https:\/\/www.publichealthontario.ca\/en\/data-and-analysis\/infectious-disease\/vaccine-safety\/vaccine-safety-surveillance-archive. Accessed 2021-10-24.","key":"609_CR1"},{"unstructured":"Canada Vigilance adverse reaction online database. (2021). https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/medeffect-canada\/adverse-reaction-database.html. Accessed 2021-12-01.","key":"609_CR2"},{"doi-asserted-by":"crossref","unstructured":"Canadian Institute for Health Information. (2019). Prescribed Drug Spending in Canada, 2019: A Focus on Public Drug Programs. https:\/\/www.cihi.ca\/en\/prescribed-drug-spending-in-canada-2019. Accessed 2021-10-24.","key":"609_CR3","DOI":"10.12927\/hcq.2020.26145"},{"key":"609_CR4","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/s0264-410x(99)00292-3","volume":"17","author":"RT Chen","year":"1999","unstructured":"Chen, R. T. (1999). Vaccine risks: Real, perceived and unknown. Vaccine, 17, S41\u2013S46. https:\/\/doi.org\/10.1016\/s0264-410x(99)00292-3","journal-title":"Vaccine"},{"unstructured":"COVID-19 vaccination in Canada. (2021). https:\/\/health-infobase.canada.ca\/covid-19\/vaccination-coverage\/. Accessed 2021-10-17.","key":"609_CR5"},{"doi-asserted-by":"publisher","unstructured":"Destefano, F., Offit, P. A., & Fisher, A. (2018). Vaccine safety. Plotkin\u2019s Vaccines, 1584\u20131600.e10. PMC. https:\/\/doi.org\/10.1016\/B978-0-323-35761-6.00082-1","key":"609_CR6","DOI":"10.1016\/B978-0-323-35761-6.00082-1"},{"issue":"15\u201316","key":"609_CR7","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.vaccine.2004.01.010","volume":"22","author":"P Duclos","year":"2004","unstructured":"Duclos, P. (2004). A global perspective on vaccine safety. Vaccine, 22(15\u201316), 2059\u20132063. https:\/\/doi.org\/10.1016\/j.vaccine.2004.01.010","journal-title":"Vaccine"},{"unstructured":"Food and Drug Regulations (C.R.C., c. 870). (2021). Justice Laws Website. https:\/\/laws-lois.justice.gc.ca\/PDF\/C.R.C.,_c._870.pdf. Accessed 2021-01-03.","key":"609_CR8"},{"unstructured":"Frank, K., & Arim, R. (2020). Canadians\u2019 willingness to get a COVID-19 vaccine: Group differences and reasons for vaccine hesitancy. Statistics Canada. https:\/\/www150.statcan.gc.ca\/n1\/en\/pub\/45-28-0001\/2020001\/article\/00073-eng.pdf?st=HwQvZdw3. Accessed 2021-04-15.","key":"609_CR9"},{"issue":"34","key":"609_CR10","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1016\/j.vaccine.2015.04.042","volume":"33","author":"S Goldstein","year":"2015","unstructured":"Goldstein, S., MacDonald, N. E., & Guirguis, S. (2015). Health communication and vaccine hesitancy. Vaccine, 33(34), 4212\u20134214. https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.042","journal-title":"Vaccine"},{"unstructured":"Hales, C. M., & Kohen, D. (2019). Prescription drug use among adults aged 40\u201379 in the United States and Canada (No. 347; NCHS Data Brief, p. 8). U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. https:\/\/pubmed.ncbi.nlm.nih.gov\/31442200\/. Accessed 2021-10-17.","key":"609_CR11"},{"issue":"5","key":"609_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell, L., & Shakir, S. A. W. (2006). Under-reporting of adverse drug reactions. Drug Safety, 29(5), 385\u2013396. https:\/\/doi.org\/10.2165\/00002018-200629050-00003","journal-title":"Drug Safety"},{"unstructured":"Health Canada. (2019). Mandatory reporting of serious adverse drug reactions and medical device incidents by hospitals. [Guidance Document]. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/medeffect-canada\/adverse-reaction-reporting\/mandatory-hospital-reporting\/drugs-devices\/guidance.html. Accessed 2021-10-24.","key":"609_CR13"},{"unstructured":"Health Canada. (2020). Regulating vaccines for human use in Canada. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/biologics-radiopharmaceuticals-genetic-therapies\/activities\/fact-sheets\/regulation-vaccines-human-canada.html. Accessed 2021-10-17.","key":"609_CR14"},{"issue":"17\u201319","key":"609_CR15","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/S0264-410X(00)00467-9","volume":"19","author":"RM Jacobson","year":"2001","unstructured":"Jacobson, R. M., Adegbenro, A., Pankratz, V. S., & Poland, G. A. (2001). Adverse events and vaccination-the lack of power and predictability of infrequent events in pre-licensure study. Vaccine, 19(17\u201319), 2428\u20132433. https:\/\/doi.org\/10.1016\/S0264-410X(00)00467-9","journal-title":"Vaccine"},{"issue":"9790","key":"609_CR16","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S0140-6736(11)60678-8","volume":"378","author":"HJ Larson","year":"2011","unstructured":"Larson, H. J., Cooper, L. Z., Eskola, J., Katz, S. L., & Ratzan, S. (2011). Addressing the vaccine confidence gap. The Lancet, 378(9790), 526\u2013535. https:\/\/doi.org\/10.1016\/S0140-6736(11)60678-8","journal-title":"The Lancet"},{"key":"609_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ebiom.2016.08.042","volume":"12","author":"HJ Larson","year":"2016","unstructured":"Larson, H. J., de Figueiredo, A., Xiahong, Z., Schulz, W. S., Verger, P., Johnston, I. G., Cook, A. R., & Jones, N. S. (2016). The state of vaccine confidence 2016: Global insights through a 67-country survey. EBioMedicine, 12, 295\u2013301. https:\/\/doi.org\/10.1016\/j.ebiom.2016.08.042","journal-title":"EBioMedicine"},{"issue":"34","key":"609_CR18","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","volume":"33","author":"NE MacDonald","year":"2015","unstructured":"MacDonald, N. E. (2015). Vaccine hesitancy: Definition, scope and determinants. Vaccine, 33(34), 4161\u20134164. https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.036","journal-title":"Vaccine"},{"issue":"1","key":"609_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.12927\/hcq.2020.26140","volume":"23","author":"TS Maity","year":"2020","unstructured":"Maity, T. S., & Longo, C. J. (2020). Adverse drug reactions in Canada (2009\u20132018): Insights from the Canada Vigilance Database. Healthcare Quarterly, 23(1), 40\u201346. https:\/\/doi.org\/10.12927\/hcq.2020.26140","journal-title":"Healthcare Quarterly"},{"issue":"1","key":"609_CR20","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1186\/s12913-021-07260-z","volume":"21","author":"T Maity","year":"2021","unstructured":"Maity, T., & Longo, C. (2021). Pragmatic pharmacoeconomic analyses by using post-market adverse drug reaction reports: An illustration using infliximab, adalimumab, and the Canada vigilance adverse reaction database. BMC Health Services Research, 21(1), 1231. https:\/\/doi.org\/10.1186\/s12913-021-07260-z","journal-title":"BMC Health Services Research"},{"doi-asserted-by":"crossref","unstructured":"Morrow, J., Seikh, N., Schmidt, C., & Davies, H. (2012). Vaccinology: Principles and practice. Wiley.","key":"609_CR21","DOI":"10.1002\/9781118345313"},{"issue":"1","key":"609_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41467-020-20226-9","volume":"12","author":"J Murphy","year":"2021","unstructured":"Murphy, J., Valli\u00e8res, F., Bentall, R. P., Shevlin, M., McBride, O., Hartman, T. K., McKay, R., Bennett, K., Mason, L., Gibson-Miller, J., Levita, L., Martinez, A. P., Stocks, T. V. A., Karatzias, T., & Hyland, P. (2021). Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nature Communications, 12(1), 29. https:\/\/doi.org\/10.1038\/s41467-020-20226-9","journal-title":"Nature Communications"},{"unstructured":"Population estimates on July 1st, by age and sex. (2021). Statistics Canada. https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1710000501. Accessed 2021-09-29.","key":"609_CR23"}],"container-title":["Canadian Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.17269\/s41997-022-00609-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.17269\/s41997-022-00609-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.17269\/s41997-022-00609-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T11:07:33Z","timestamp":1744196853000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.17269\/s41997-022-00609-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["609"],"URL":"https:\/\/doi.org\/10.17269\/s41997-022-00609-9","relation":{},"ISSN":["0008-4263","1920-7476"],"issn-type":[{"type":"print","value":"0008-4263"},{"type":"electronic","value":"1920-7476"}],"subject":[],"published":{"date-parts":[[2022,2,11]]},"assertion":[{"value":"3 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}